Nano-Metal Hydrogen Therapy Targeting Immune Cells Drives Synergistic Anti-Tumor Effects
Molecules · 2026
DOI: 10.3390/molecules31173058 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, 2026. Verfasst von Yuxuan Ding und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Health, China Agricultural University, Beijing 100193, China. Hauptthemen laut MEDLINE: Hydrogen, Neoplasms, Antineoplastic Agents, Metal Nanoparticles. Die Arbeit nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Hydrogen is employed as a therapeutic gas in the treatment of stroke, tissue repair, and cancer, owing to its excellent biocompatibility, antioxidant properties, anti-inflammatory effects, and regulation of cellular metabolism. Moreover, nanometallic materials generate hydrogen through pH-responsive, light-responsive, ultrasound-responsive, and electrical stimulation and play a pivotal role in cancer therapy by activating anti-tumor immune responses, reversing immunosuppressive microenvironments, inducing immunogenic cell death, and sensitising radiotherapy and chemotherapy. Consequently, hydrogen therapy based on nanometallic materials has emerged as a novel research focus in cancer treatment. This review systematically elucidates the unique anti-cancer immunobiological effects of hydrogen therapy based on novel nanometallic materials. It meticulously analyses the reversal effects of different metals (Ca, Mg, Fe, Cu, Yb, etc.) in overcoming obstacles within the cancer immune cycle (including antigen presentation, T-cell activation, and resistance mechanisms). It highlights the structure–activity relationships between ‘metal type-specific activity-immune effects’ in the latest hydrogen therapies, elucidates the primary signaling pathways involved in hydrogen-mediated immune regulation, and systematically summarises breakthrough advances in how hydrogen therapy modulates immune responses against tumors. Building upon current cancer treatment trends, this review will synthesise key factors from clinical translation and immunological research perspectives to propose future directions for the field, addressing prevailing challenges.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Health, China Agricultural University, Beijing 100193, China.
- Key Laboratory of Precision Nutrition and Food Quality, Beijing 100193, China.
- Beijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing 100193, China.
ORCID-Profile: Libing Liu
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Ding, Y., Ma, M., Wang, J., Zhang, Z., Wu, J., Zhou, L., Cao, X., & Liu, L. (2026). Nano-Metal Hydrogen Therapy Targeting Immune Cells Drives Synergistic Anti-Tumor Effects. Molecules. https://doi.org/10.3390/molecules31173058
Vancouver
Ding Y, Ma M, Wang J, Zhang Z, Wu J, Zhou L, et al. Nano-Metal Hydrogen Therapy Targeting Immune Cells Drives Synergistic Anti-Tumor Effects. Molecules. 2026. doi:10.3390/molecules31173058
BibTeX
@article{Ding2026,
author = {Ding, Yuxuan and Ma, Min and Wang, Jianing and Zhang, Zixin and Wu, Jingyu and Zhou, Linxiang and Cao, Xiaoyan and Liu, Libing},
title = {Nano-Metal Hydrogen Therapy Targeting Immune Cells Drives Synergistic Anti-Tumor Effects},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31173058}
}
EUVIMED